Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,478
Total Claims
$1.1M
Drug Cost
685
Beneficiaries
$1,581
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-1%
Opioid rate vs peers
2.2% vs 2.2% avg
+12%
Cost per patient vs peers
$1,581 vs $1,411 avg
+16%
Brand preference vs peers
12.3% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.2%
Opioid Rate
233
Opioid Claims
$6,952
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,279 claims · $840K
Generic: 9,136 claims · $240K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 152 | $198K |
| Semaglutide | 99 | $136K |
| Empagliflozin | 49 | $66K |
| Rivaroxaban | 46 | $62K |
| Dulaglutide | 27 | $54K |
| Mirabegron | 25 | $24K |
| Insulin Glargine,hum.Rec.Anlog | 20 | $23K |
| Budesonide/Formoterol Fumarate | 41 | $22K |
| Insulin Glargine,hum.Rec.Anlog | 27 | $20K |
| Insulin Lispro | 15 | $19K |
| Insulin Glargine,hum.Rec.Anlog | 23 | $19K |
| Insulin Aspart | 12 | $13K |
| Levothyroxine Sodium | 586 | $12K |
| Insulin Lispro | 12 | $11K |
| Rosuvastatin Calcium | 508 | $9,475 |
Prescribing Profile
Patient Profile
73
Avg Age
58%
Female
0.91
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About